Literature DB >> 12969333

Mouse urogenital development: a practical approach.

Andrea Staack1, Annemarie A Donjacour, Joel Brody, Gerald R Cunha, Peter Carroll.   

Abstract

A detailed knowledge of the developmental anatomy of the embryonic mouse urogenital tract is required to recognize mutant urogenital phenotypes in transgenic and knock-out mice. Accordingly, the purpose of this article is to review urogenital development in the mouse embryo and to give an illustrated methodological protocol for the dissection of urogenital organ rudiments at 12-13 days of gestation (E12-13) to isolate the urogenital ridge and at E16 to isolate the seminal vesicle, Müllerian duct, Wolffian duct, and prostatic rudiment, the urogenital sinus (UGS). The UGS can be cultured and, in the presence of testosterone, prostatic buds form in vitro. Because of the importance of mesenchymal-epithelial interactions in urogenital development, methods for the isolation of epithelium and mesenchyme from the embryonic urogenital sinus are also described. Urogenital sinus mesenchyme (UGM) and urogenital sinus epithelium (UGE) can be used to construct tissue recombinants that can either be grown in vitro or grafted in vivo for the study of epithelial-mesenchymal interactions in prostatic development.

Entities:  

Mesh:

Year:  2003        PMID: 12969333     DOI: 10.1046/j.1432-0436.2003.7107004.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  58 in total

1.  Cell death serves as a single etiological cause of a wide spectrum of congenital urinary tract defects.

Authors:  Qiusha Guo; Piyush Tripathi; Edward Poyo; Yinqiu Wang; Paul F Austin; Carlton M Bates; Feng Chen
Journal:  J Urol       Date:  2011-04-21       Impact factor: 7.450

Review 2.  The road to maleness: from testis to Wolffian duct.

Authors:  Ivraym Barsoum; Humphrey Hung-Chang Yao
Journal:  Trends Endocrinol Metab       Date:  2006-07-05       Impact factor: 12.015

3.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

4.  Dual-label centromere and telomere FISH identifies human, rat, and mouse cell contribution to Multispecies recombinant urogenital sinus xenografts.

Authors:  Donald J Vander Griend; Yuko Konishi; Angelo M De Marzo; John T Isaacs; Alan K Meeker
Journal:  Prostate       Date:  2009-10-01       Impact factor: 4.104

Review 5.  Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions.

Authors:  Aubie Shaw; Steven Attia; Wade Bushman
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

6.  Novel domains of expression for orphan receptor tyrosine kinase Ror2 in the human and mouse reproductive system.

Authors:  Ripla Arora; Eran Altman; Nam D Tran; Diana J Laird
Journal:  Dev Dyn       Date:  2014-05-06       Impact factor: 3.780

Review 7.  Development and morphogenesis of the Wolffian/epididymal duct, more twists and turns.

Authors:  Avenel Joseph; Humphrey Yao; Barry T Hinton
Journal:  Dev Biol       Date:  2008-11-01       Impact factor: 3.582

8.  NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.

Authors:  David C Austin; Douglas W Strand; Harold L Love; Omar E Franco; Magdalena M Grabowska; Nicole L Miller; Omar Hameed; Peter E Clark; Robert J Matusik; Ren J Jin; Simon W Hayward
Journal:  Prostate       Date:  2016-05-16       Impact factor: 4.104

Review 9.  Mesenchymal-epithelial interaction techniques.

Authors:  Gerald R Cunha; Lawrence Baskin
Journal:  Differentiation       Date:  2015-11-21       Impact factor: 3.880

Review 10.  A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium.

Authors:  Chris Mullins; M Scott Lucia; Simon W Hayward; Jeannette Y Lee; Jonathan M Levitt; Victor K Lin; Brian C-S Liu; Arul M Chinnaiyan; Mark A Rubin; Kevin Slawin; Robert A Star; Robert H Getzenberg
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.